Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Hand, Foot And Mouth Disease - Pipeline Review, H1 2015

Published: Jan-2015 | Format: PDF | Global Markets Direct | Number of pages: 43 | Code: MRS - 18150


Global Markets Directs, Hand, Foot And Mouth Disease Pipeline Review, H1 2015, provides an overview of the Hand, Foot And Mouth Diseases therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Hand, Foot And Mouth Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hand, Foot And Mouth Disease and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides a snapshot of the global therapeutic landscape of Hand, Foot And Mouth Disease
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Hand, Foot And Mouth Disease and enlists all their major and minor projects
The report summarizes all the dormant and discontinued pipeline projects 
A review of the Hand, Foot And Mouth Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
A detailed assessment of monotherapy and combination therapy pipeline projects
Coverage of the Hand, Foot And Mouth Disease pipeline on the basis of target, MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products

Reasons to buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading companies
Identify and understand important and diverse types of therapeutics under development for Hand, Foot And Mouth Disease
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Devise corrective measures for pipeline projects by understanding Hand, Foot And Mouth Disease pipeline depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table Of Content

Table of Contents 2
List of Tables 4
List of Figures 4

Introduction 5
Global Markets Direct Report Coverage 5
Hand, Foot And Mouth Disease Overview 6
Therapeutics Development 7
Pipeline Products for Hand, Foot And Mouth Disease - Overview 7
Pipeline Products for Hand, Foot And Mouth Disease - Comparative Analysis 8
Hand, Foot And Mouth Disease - Therapeutics under Development by Companies 9
Hand, Foot And Mouth Disease - Pipeline Products Glance 10
Late Stage Products 10
Clinical Stage Products 11
Early Stage Products 12
Hand, Foot And Mouth Disease - Products under Development by Companies 13
Hand, Foot And Mouth Disease - Companies Involved in Therapeutics Development 14
Chongqing Zhifei Biological Products Co., Ltd. 14
CJ CheilJedang Corp. 15
iQur Ltd. 16
Sentinext Therapeutics Sdn Bhd 17
Sinovac Biotech Ltd. 18
Takeda Pharmaceutical Company Limited 19
Hand, Foot And Mouth Disease - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Route of Administration 21
Assessment by Molecule Type 22
Drug Profiles 24
CJ-40010 - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
enterovirus [type 71] vaccine - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
foot and mouth disease virus like particle vaccine - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
hand foot and mouth disease vaccine - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
hand, foot and mouth (bivalent) viral like particle vaccine - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
INV-21 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Hand, Foot And Mouth Disease - Recent Pipeline Updates 31
Hand, Foot And Mouth Disease - Product Development Milestones 34
Featured News & Press Releases 34
Apr 24, 2014: Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project 34
Feb 26, 2014: Sinovac's EV71 Vaccine Phase III Clinical Trial Results Published in New England Journal of Medicine 34
May 30, 2013: Sinovac Files New Drug Application For EV71 Vaccine And Receives Filing Acceptance From Beijing Drug Administration 35
Apr 18, 2013: Sinovac Announces Presentation Of EV71 Vaccine Phase III Top-Line Results At 13th Annual World Vaccine Congress & Expo 36
Mar 14, 2013: Sinovac Reports Positive Preliminary Top-Line Results From Phase III Clinical Trial For EV71 Vaccine Candidate Against Hand, Foot and Mouth Disease 36
Jun 25, 2012: Sinovac Reports Progress In EV71 Vaccine Phase III Clinical Trial And Commercialization Preparation Status 37
Jun 11, 2012: Sinovac Reports Progress In EV71 Vaccine Phase III Clinical Trial 38
Mar 29, 2012: Sinovac Announces Publication Of Phase I Clinical Data Of EV71 Vaccine For Prevention Of Hand, Foot And Mouth Disease In Journal Vaccine 38
Mar 11, 2012: Inviragen Reports Top-Line Results From Phase I Trial Of INV21 Vaccine For Treatment Of Hand, Foot And Mouth Disease 40
Jan 10, 2012: Sinovac Commences Phase III Clinical Trial For EV71 Vaccine Against Hand, Foot And Mouth Disease 40

Appendix 42
Methodology 42
Coverage 42
Secondary Research 42
Primary Research 42
Expert Panel Validation 42
Contact Us 42
Disclaimer 43

List of Tables

Number of Products under Development for Hand, Foot And Mouth Disease, H1 2015 7
Number of Products under Development for Hand, Foot And Mouth Disease - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Late Stage Development, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Comparative Analysis by Early Stage Development, H1 2015 12
Products under Development by Companies, H1 2015 13
Hand, Foot And Mouth Disease - Pipeline by Chongqing Zhifei Biological Products Co., Ltd., H1 2015 14
Hand, Foot And Mouth Disease - Pipeline by CJ CheilJedang Corp., H1 2015 15
Hand, Foot And Mouth Disease - Pipeline by iQur Ltd., H1 2015 16
Hand, Foot And Mouth Disease - Pipeline by Sentinext Therapeutics Sdn Bhd, H1 2015 17
Hand, Foot And Mouth Disease - Pipeline by Sinovac Biotech Ltd., H1 2015 18
Hand, Foot And Mouth Disease - Pipeline by Takeda Pharmaceutical Company Limited, H1 2015 19
Assessment by Monotherapy Products, H1 2015 20
Number of Products by Stage and Route of Administration, H1 2015 21
Number of Products by Stage and Molecule Type, H1 2015 23
Hand, Foot And Mouth Disease Therapeutics - Recent Pipeline Updates, H1 2015 31

List of Figures

Number of Products under Development for Hand, Foot And Mouth Disease, H1 2015 7
Number of Products under Development for Hand, Foot And Mouth Disease - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Early Stage Products, H1 2015 12
Assessment by Monotherapy Products, H1 2015 20
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 21
Number of Products by Top 10 Molecule Types, H1 2015 22
Number of Products by Stage and Top 10 Molecule Types, H1 2015 23

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2000 View Pricing